ImmunoPrecise Antibodies appoints Board member Mitch Levine as Chairman of the Board of Directors

– CANADA, Victoria –  ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-driven biotherapeutic research and technology, today announced the appointment of Mitch Levine as Chairman of the Board of Directors, bringing a wealth of experience from the life sciences industry and financial strategy, particularly in Nasdaq market operations.…